Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
431 | 3453 | 46.4 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
429 | 3 | SPHINGOSINE 1 PHOSPHATE//CERAMIDE//SPHINGOLIPIDS | 27734 |
1124 | 2 | SPHINGOSINE 1 PHOSPHATE//CERAMIDE//SPHINGOLIPIDS | 9675 |
431 | 1 | SPHINGOSINE 1 PHOSPHATE//FTY720//SPHINGOSINE KINASE | 3453 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SPHINGOSINE 1 PHOSPHATE | authKW | 4877354 | 24% | 66% | 842 |
2 | FTY720 | authKW | 2331531 | 10% | 79% | 334 |
3 | SPHINGOSINE KINASE | authKW | 2004054 | 8% | 78% | 290 |
4 | FINGOLIMOD | authKW | 995940 | 6% | 55% | 205 |
5 | SPHINGOSINE KINASE 1 | authKW | 660174 | 3% | 77% | 97 |
6 | SPHINGOSINE 1 PHOSPHATE RECEPTOR | authKW | 495189 | 2% | 81% | 69 |
7 | S1P | authKW | 492827 | 3% | 54% | 104 |
8 | S1P RECEPTORS | authKW | 384772 | 2% | 81% | 54 |
9 | SPHINGOSINE 1 PHOSPHATE S1P | authKW | 319361 | 1% | 71% | 51 |
10 | S1P1 | authKW | 308662 | 1% | 78% | 45 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 3938 | 19% | 0% | 646 |
2 | Biochemistry & Molecular Biology | 3367 | 29% | 0% | 991 |
3 | Immunology | 2154 | 14% | 0% | 467 |
4 | Transplantation | 1574 | 5% | 0% | 166 |
5 | Chemistry, Medicinal | 1209 | 6% | 0% | 216 |
6 | Pharmacology & Pharmacy | 1163 | 13% | 0% | 451 |
7 | Biophysics | 743 | 6% | 0% | 220 |
8 | Hematology | 355 | 4% | 0% | 135 |
9 | Oncology | 344 | 7% | 0% | 253 |
10 | Peripheral Vascular Diseases | 245 | 3% | 0% | 112 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOMEMBRANE BIOFUNCT CHEM | 126755 | 1% | 31% | 47 |
2 | CELLULAR MOL REGULAT | 80565 | 1% | 20% | 46 |
3 | GENET DEV DIS BRANCH | 58234 | 1% | 13% | 49 |
4 | GENET DIS DEV BRANCH | 39783 | 0% | 75% | 6 |
5 | EXPT SURG BIOENGN | 31854 | 0% | 23% | 16 |
6 | IMMUNOL 3 | 28930 | 0% | 55% | 6 |
7 | HELEN L DORRIS CHILD ADOLESCENT NEUROPSYCHIAT D | 28507 | 0% | 32% | 10 |
8 | BIOACT LIPID PROGRAM | 28290 | 0% | 80% | 4 |
9 | TULANE PHARMACOL | 28290 | 0% | 80% | 4 |
10 | NOVARTIS PHARMA | 27069 | 0% | 44% | 7 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 16981 | 2% | 3% | 72 |
2 | CELLULAR SIGNALLING | 3511 | 1% | 1% | 42 |
3 | MULTIPLE SCLEROSIS AND RELATED DISORDERS | 3418 | 0% | 3% | 12 |
4 | FASEB JOURNAL | 3028 | 2% | 1% | 58 |
5 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 2549 | 1% | 1% | 23 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1851 | 2% | 0% | 75 |
7 | ACS MEDICINAL CHEMISTRY LETTERS | 1829 | 0% | 1% | 17 |
8 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1807 | 5% | 0% | 189 |
9 | MULTIPLE SCLEROSIS JOURNAL | 1474 | 1% | 1% | 20 |
10 | TRANSPLANTATION PROCEEDINGS | 1383 | 2% | 0% | 83 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SPHINGOSINE 1 PHOSPHATE | 4877354 | 24% | 66% | 842 | Search SPHINGOSINE+1+PHOSPHATE | Search SPHINGOSINE+1+PHOSPHATE |
2 | FTY720 | 2331531 | 10% | 79% | 334 | Search FTY720 | Search FTY720 |
3 | SPHINGOSINE KINASE | 2004054 | 8% | 78% | 290 | Search SPHINGOSINE+KINASE | Search SPHINGOSINE+KINASE |
4 | FINGOLIMOD | 995940 | 6% | 55% | 205 | Search FINGOLIMOD | Search FINGOLIMOD |
5 | SPHINGOSINE KINASE 1 | 660174 | 3% | 77% | 97 | Search SPHINGOSINE+KINASE+1 | Search SPHINGOSINE+KINASE+1 |
6 | SPHINGOSINE 1 PHOSPHATE RECEPTOR | 495189 | 2% | 81% | 69 | Search SPHINGOSINE+1+PHOSPHATE+RECEPTOR | Search SPHINGOSINE+1+PHOSPHATE+RECEPTOR |
7 | S1P | 492827 | 3% | 54% | 104 | Search S1P | Search S1P |
8 | S1P RECEPTORS | 384772 | 2% | 81% | 54 | Search S1P+RECEPTORS | Search S1P+RECEPTORS |
9 | SPHINGOSINE 1 PHOSPHATE S1P | 319361 | 1% | 71% | 51 | Search SPHINGOSINE+1+PHOSPHATE+S1P | Search SPHINGOSINE+1+PHOSPHATE+S1P |
10 | S1P1 | 308662 | 1% | 78% | 45 | Search S1P1 | Search S1P1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VOGT, D , STARK, H , (2017) THERAPEUTIC STRATEGIES AND PHARMACOLOGICAL TOOLS INFLUENCING S1P SIGNALING AND METABOLISM.MEDICINAL RESEARCH REVIEWS. VOL. 37. ISSUE 1. P. 3 -51 | 323 | 75% | 0 |
2 | ALSHAKER, H , SAUER, L , MONTEIL, D , OTTAVIANI, S , SRIVATS, S , BOHLER, T , PCHEJETSKI, D , (2013) THERAPEUTIC POTENTIAL OF TARGETING SK1 IN HUMAN CANCERS.ROLE OF SPHINGOLIPIDS IN CANCER DEVELOPMENT AND THERAPY. VOL. 117. ISSUE . P. 143-200 | 268 | 87% | 18 |
3 | TAKABE, K , PAUGH, SW , MILSTIEN, S , SPIEGEL, S , (2008) "INSIDE-OUT" SIGNALING OF SPHINGOSINE-1-PHOSPHATE: THERAPEUTIC TARGETS.PHARMACOLOGICAL REVIEWS. VOL. 60. ISSUE 2. P. 181-195 | 168 | 88% | 300 |
4 | BIGAUD, M , GUERINI, D , BILLICH, A , BASSILANA, F , BRINKMANN, V , (2014) SECOND GENERATION S1P PATHWAY MODULATORS: RESEARCH STRATEGIES AND CLINICAL DEVELOPMENTS.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1841. ISSUE 5. P. 745-758 | 162 | 93% | 39 |
5 | SCHUCHARDT, M , TOLLE, M , PRUFER, J , VAN DER GIET, M , (2011) PHARMACOLOGICAL RELEVANCE AND POTENTIAL OF SPHINGOSINE 1-PHOSPHATE IN THE VASCULAR SYSTEM.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 163. ISSUE 6. P. 1140 -1162 | 231 | 84% | 27 |
6 | WHITE, C , ALSHAKER, H , COOPER, C , WINKLER, M , PCHEJETSKI, D , (2016) THE EMERGING ROLE OF FTY720 (FINGOLIMOD) IN CANCER TREATMENT.ONCOTARGET. VOL. 7. ISSUE 17. P. 23106 -23127 | 188 | 80% | 2 |
7 | PYNE, NJ , PYNE, S , (2010) SPHINGOSINE 1-PHOSPHATE AND CANCER.NATURE REVIEWS CANCER. VOL. 10. ISSUE 7. P. 489 -503 | 145 | 77% | 305 |
8 | BRINKMANN, V , (2007) SPHINGOSINE 1-PHOSPHATE RECEPTORS IN HEALTH AND DISEASE: MECHANISTIC INSIGHTS FROM GENE DELETION STUDIES AND REVERSE PHARMACOLOGY.PHARMACOLOGY & THERAPEUTICS. VOL. 115. ISSUE 1. P. 84-105 | 157 | 83% | 280 |
9 | MARFE, G , MIRONE, G , SHUKLA, A , DI STEFANO, C , (2015) SPHINGOSINE KINASES SIGNALLING IN CARCINOGENESIS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 15. ISSUE 4. P. 300 -314 | 166 | 86% | 5 |
10 | TAHA, TA , HANNUN, YA , OBEID, LM , (2006) SPHINGOSINE KINASE: BIOCHEMICAL AND CELLULAR REGULATION AND ROLE IN DISEASE.JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 39. ISSUE 2. P. 113-131 | 165 | 89% | 182 |
Classes with closest relation at Level 1 |